Becton, Dickinson and Company (BDX)
NYSE: BDX · Real-Time Price · USD
227.68
+3.85 (1.72%)
Dec 20, 2024, 4:00 PM EST - Market closed

BDX Revenue

In the fiscal year ending September 30, 2024, Becton, Dickinson and Company had annual revenue of $20.18B with 4.16% growth. Becton, Dickinson and Company had revenue of $5.44B in the quarter ending September 30, 2024.

Revenue (ttm)
$20.18B
Revenue Growth
+4.16%
P/S Ratio
3.27
Revenue / Employee
$276,411
Employees
73,000
Market Cap
65.83B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Sep 30, 202420.18B806.00M4.16%
Sep 30, 202319.37B502.00M2.66%
Sep 30, 202218.87B-261.00M-1.36%
Sep 30, 202119.13B3.06B19.02%
Sep 30, 202016.07B-1.22B-7.03%
Sep 30, 2019 Pro Pro Pro
Sep 30, 2018 Pro Pro Pro
Sep 30, 2017 Pro Pro Pro
Sep 30, 2016 Pro Pro Pro
Sep 30, 2015 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
CVS Health 367.25B
McKesson 330.19B
Cencora 293.96B
HCA Healthcare 69.62B
GSK 41.97B
Haleon 15.07B
Regeneron Pharmaceuticals 13.85B
Alcon 9.76B
Revenue Rankings